You have 9 free searches left this month | for more free features.

AGT

Showing 1 - 25 of 98

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypertension Trial in Edinburgh, London, Manchester (ALN-AGT01, ALN-AGT01-Matching Placebo, Irbesartan)

Completed
  • Hypertension
  • Edinburgh, United Kingdom
  • +2 more
Jan 13, 2023

Primary Hypercholesterolemia Trial in Seoul (AGT2, AGZ, AGT2, AGT4, AGZ)

Recruiting
  • Primary Hypercholesterolemia
  • AGT2, AGZ
  • +3 more
  • Seoul, Korea, Republic of
    Yonsei severance Hospital
Jan 12, 2022

Assisted Reproductive Technology Trial in Mansoura (Assisted gamete activation)

Completed
  • Assisted Reproductive Technology
  • Assisted gamete activation
  • Mansoura, Daqahlya, Egypt
    Royal Fertility Center
Sep 18, 2022

HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))

Enrolling by invitation
  • HIV
  • Antiretroviral Therapy Interruption(ATI)
  • Washington, District of Columbia
  • +1 more
Sep 12, 2022

Hypertension Trial in United States (IONIS-AGT-LRx, Placebo)

Completed
  • Hypertension
  • Placebo
  • ISIS 757456
  • Birmingham, Alabama
  • +8 more
Dec 21, 2022

Chronic Heart Failure With Reduced Ejection Fraction Trial in Hungary, Poland, United States (IONIS-AGT-LRx, Placebo)

Active, not recruiting
  • Chronic Heart Failure With Reduced Ejection Fraction
  • Little Rock, Arkansas
  • +25 more
Jul 27, 2022

PH1, Primary Hyperoxaluria, RNAi Therapeutic Trial in Worldwide (Lumasiran)

Active, not recruiting
  • PH1
  • +4 more
  • Bordeaux, France
  • +8 more
Jan 13, 2023

Hypertension Trial in Canada, United States (IONIS-AGT-LRx, Placebo)

Active, not recruiting
  • Hypertension
  • Anniston, Alabama
  • +49 more
Aug 6, 2022

Mild Hypertension Trial in United States (IONIS-AGT-LRx, Placebo)

Completed
  • Mild Hypertension
  • Tustin, California
  • +5 more
Nov 12, 2020

HIV Trial in Washington (AGT103-T)

Recruiting
  • HIV
  • AGT103-T
  • Washington, District of Columbia
  • +1 more
May 12, 2021

Hypertension Trial in Worldwide (Placebo, ALN-AGT01)

Recruiting
  • Hypertension
  • Birmingham, Alabama
  • +112 more
Dec 16, 2022

Hypertension Trial in United States (ION904, Placebo)

Recruiting
  • Hypertension
  • Cypress, California
  • +7 more
Aug 4, 2022

MDD Trial in United States (Assay-guided treatment (AGT), Treatment-as-usual (TAU))

Completed
  • Major Depressive Disorder
  • Assay-guided treatment (AGT)
  • Treatment-as-usual (TAU)
  • Birmingham, Alabama
  • +22 more
Aug 27, 2020

Type 2 Diabetes, Hypertension Trial in New Orleans (Dapagliflozin, Sulfonylurea, Placebo)

Completed
  • Type 2 Diabetes
  • Hypertension
  • New Orleans, Louisiana
    Tulane University
Oct 5, 2022

Diabetes Trial in Boston (Para-aminohippuric Acid, Angiotensin II, Norepinephrine)

Terminated
  • Diabetes Mellitus
  • Para-aminohippuric Acid
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital- 221 Longwood Avenue
Nov 7, 2022

CT-guided Sarcopenia for Surgical Outcomes in Esophagetomy and

Completed
  • Sarcopenia
  • +4 more
    • Barretos, São Paulo, Brazil
      Barretos Cancer Hospital
    Feb 9, 2023

    Hypertension Trial in Worldwide (Olmesartan, Amlodipine, Indapamide)

    Recruiting
    • Hypertension
    • Birmingham, Alabama
    • +119 more
    Jan 13, 2023

    Old Age, Fall Trial in Rawalpindi (Normal treadmill, Anti-gravity treadmill with lower limb positive pressure, Anti-gravity

    Recruiting
    • Old Age
    • Fall
    • Normal treadmill
    • +2 more
    • Rawalpindi, Punjab, Pakistan
      Fauji Foundation Hospital
    Aug 5, 2021

    Hypoglycemia and Glucagon Response in CF

    Completed
    • Cystic Fibrosis
    • +3 more
      • Istanbul, Turkey
        Marmara University, School of Medicine
      Jan 25, 2023

      Primary Ovarian Insufficiency, Cardiovascular Diseases, Menopause, Premature Trial in Ryazan (Taking a person's venous blood)

      Active, not recruiting
      • Primary Ovarian Insufficiency
      • +6 more
      • Taking a person's venous blood
      • Ryazan, Ryazan Region, Russian Federation
        Sergey Vladimirovich Lopukhov
      Aug 3, 2022

      MDD Trial in Nashville (Genecept Assay)

      Terminated
      • Major Depressive Disorder
      • Genecept Assay
      • Nashville, Tennessee
        Centerstone
      Aug 16, 2021

      Hemophilia B Trial in United Kingdom, United States (Gene Transfer, scAAV2/8-LP1-hFIXco)

      Active, not recruiting
      • Hemophilia B
      • Stanford, California
      • +7 more
      Nov 17, 2022

      Myocardial Injury and Dysfunction Associated With COVID-19

      Recruiting
      • Myocardial Injury
      • +2 more
        • Aurora, Colorado
          University of Colorado Anschutz Medical Campus
        May 2, 2022

        Mucopolysaccharidosis I Trial (AGT-181)

        Completed
        • Mucopolysaccharidosis I
        • (no location specified)
        Sep 21, 2018

        Mucopolysaccharidosis I Trial in Porto Alegre (AGT-181)

        Completed
        • Mucopolysaccharidosis I
        • Porto Alegre, RS, Brazil
          HCPA - Hospital das Clinicas de Porto Alegre
        Sep 16, 2018